Tags

Cancer

סרטן הקיבה
New lung cancer drug adds nearly six months of survival; stomach cancer treatment doubles it
Two Phase 3 trials presented at Europe's leading oncology conference show major survival gains: Roche's divarasib outperforms existing targeted lung cancer drugs, while AstraZeneca's experimental therapy doubles median survival for certain advanced stomach cancer patients; neither has yet been approved for routine use
Oren Rice | 10.26.26
סרטן ריאות
Lung cancer breakthrough: drug combination cuts death risk by 58% in major trial
A Phase 3 trial involving 563 patients found that combining tarlatamab with immunotherapy extended median survival from 12.7 to 21.1 months; researchers hailed the results at a Madrid oncology conference, although serious side effects and treatment costs remain concerns
Oren Rice | 10.24.26
חיסונים, חיסון, מודרנה
Moderna's melanoma vaccine succeeds in major trial. So why did its stock plunge?
Moderna and Merck's personalized mRNA vaccine raised two-year recurrence-free survival to 82.2%, from 70% with Keytruda alone; despite the Phase 3 success, Moderna shares plunged 18%, overall survival remains unproven and US approval is pending
Oren Reiss | 10.24.26
חולות ומחלימות מסרטן השד מתכוננות מאחורי הקלעים של תצוגת אופנה במסגרת "אוקטובר הוורוד" בתוניס
AI analyzes a single photo to predict cancer patients' risk of death
Harvard-affiliated researchers trained AI on more than 40 million facial images, developing tools to estimate biological age and predict mortality risk among cancer patients; the public can now test one tool with a selfie, but experts warn the technology is not ready for clinical use
Oren Rice | 10.22.26
האפיפיור ליאו ה 14 לאו מפגש עם צליינים 21 אוקטובר 2026
Pope's doctors say he requires no further treatment after lung surgery
About a week after undergoing surgery to remove the lower lobe of his right lung following a lung cancer diagnosis, Pope Leo XIV's doctors say the cancer has not spread and no further treatment is needed; he met with the faithful Wednesday.
ynet, News Agencies | 10.21.26
Pope Leo XIV, accompanied by his personal secretary, Monsignor Edgard Iván Rimaycuna Inga, celebrates Mass at Rome's Gemelli Hospital on Friday while recovering from lung cancer surgery
Pope Leo XIV to leave hospital after lung cancer surgery
Pope Leo XIV is set to leave hospital Saturday, four days after lung cancer surgery, and deliver Sunday's blessing
AP, Reuters | 10.17.26
אתי וליאור זוהר
Cancer strikes twice: husband and wife diagnosed in same month, undergo chemo together
Etti and Lior Zohar, both in their 40s, were diagnosed with cancer in the same month; as he awaited bowel tumor biopsy results, she learned she had aggressive breast cancer; after undergoing chemotherapy together, they urge everyone to get checked
Yael Garty | 10.16.26
האפיפיור ליאו ה-14
Pope Leo recovering in Rome hospital after cancer diagnosis
The 71-year-old pontiff underwent a 90-minute operation to remove the lower lobe of his right lung after doctors diagnosed adenocarcinoma; the Vatican says the surgery was successful, with further medical updates expected and public engagements canceled through October 20
Reuters | 10.14.26
Phantom GI founders
Israeli startup develops 20-minute procedure for patients too sick for surgery
Israeli startup Phantom GI has raised $5 million to develop a minimally invasive device designed to relieve life-threatening bowel obstructions in about 20 minutes, offering a potential alternative for patients too ill to undergo major surgery
ynet Global | 10.09.26
פרופ' סיריל כהן
Israeli scientists redesign T cells, shrinking tumors in promising cancer study
T cells can precisely target cancer, but engineered receptors may interfere with natural ones and lose effectiveness; Bar-Ilan and Weizmann researchers designed a more stable version, with promising results in mice
Eitan Gefen | 09.30.26
בדיקת CT חזה
AI spots esophageal cancer on CT scans months before diagnosis
An AI system detected 90% of esophageal cancer cases on chest CT scans, sometimes months before diagnosis, raising the prospect that one scan could uncover multiple diseases without extra testing or radiation
Eitan Gefen | 09.28.26
תאי סרטן
Why immunotherapy works for some cancer patients but not others
Technion-led study finds early changes in tumors’ immune environment may predict treatment success better than their initial state, potentially opening path to more personalized cancer care
ynet Global | 09.27.26
מעבדה בטכניון
Beyond the breakthrough: inside the Technion labs shaping the technologies of tomorrow
From quantum computing and AI to nanoparticles designed to signal cancer cells to stop dividing, Technion researchers are building the science, engineering and talent needed for technologies whose full potential is still unknown
ynet Global | 09.17.26
ראש הסגל בבית הלבן סוזי וויילס
After six months, Trump chief of staff Susie Wiles announces: ‘I’m cancer-free’
White House chief of staff Susie Wiles says she is cancer-free after six months of breast cancer treatment, thanking her doctors and Trump for his 'unwavering support'
AP | 09.17.26
Alpha DaRT
A physics breakthrough takes aim at cancer’s toughest tumors
What began as an unlikely collision of physics and medicine has become a promising new weapon against cancer; Israel’s Alpha DaRT delivers alpha radiation from inside tumors and is now approved in Japan and advancing toward US approval
ynet Global | 09.12.26
More Articles
Hot Tags
Today
This Week
This Month
Amine AyoubAntisemitismAvigdor LibermanBakeryBen-Gurion UniversityBenjamin NetanyahuBillionairesbirthdayBloodBlood bank
Hot Tags
Today
This Week
This Month
Amine AyoubAntisemitismAvigdor LibermanBakeryBen-Gurion UniversityBenjamin NetanyahuBillionairesbirthdayBloodBlood bank
Related Tags
AIArtificial IntelligenceHealthStartupItalyhospitalsWeizmann Institute of ScienceVaccinePope Leo XIVThe Pope
""